Bayesian Capital Management, LP Bio Rad Laboratories, Inc. Transaction History
Bayesian Capital Management, LP
- $838 Million
- Q3 2024
A detailed history of Bayesian Capital Management, LP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 2,262 shares of BIO stock, worth $816,310. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,262
Previous 3,262
30.66%
Holding current value
$816,310
Previous $890,000
15.06%
% of portfolio
0.09%
Previous 0.1%
Shares
13 transactions
Others Institutions Holding BIO
# of Institutions
455Shares Held
17.7MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$688 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$560 Million0.01% of portfolio
-
Veritas Asset Management LLP1.09MShares$392 Million3.03% of portfolio
-
Van Eck Associates Corp723KShares$261 Million0.3% of portfolio
-
First Eagle Investment Management, LLC713KShares$257 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.89B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...